Request for membership to create or review content for BOPA Digital SACT passport (Update)

Dear Member,

Regarding the earlier communication for registering to become a creator/reviewer of mock prescriptions:

This process has been amended and creation/review is open to free associates and above, as opposed to paid members only.

We apologise for any confusion.

How do you contribute?

We request that you register interest to be a creator and/or reviewer of Mock Prescriptions via the following link:

https://www.bopa.org.uk/mock-rx-creator-reviewer-registration/

You can also register within the BOPA SACT Verification Hub in the Contribution to Content tile.

Our mock prescription team will be in touch and will allocate you the required mock prescription content based on your indicated role, level of verification and speciality, and will advise from there.
This is to prevent duplication of entries.

We greatly appreciate any and all contributions to the ongoing use and success of the Passport and encourage all members to get involved in the creation of content.

Please see the relevant supportive SOPs for this process which are saved within the SOP tile of the BOPA SACT Verification Hub.

If you have any queries about this process, please get it touch via email ([email protected])

Kind Regards,

BOPA Passport Pillar

 

Please appreciate these are for UK-wide use and are not unique to any one nation, Trust or cancer centre. Content may not reflect your local practice.

Latest News

By Mohammed Patel on 11th November 2026

UK BMT Pharmacists Group Educational Meeting – Friday 13th November 2026. Time:14:00 to 16:00

The next UK BMT Pharmacists Group Educational Meeting is on Friday 13th November, 2pm–4pm. The sessions include: Maintenance Therapy for AML After Allogeneic BMT with Dr Mili Shah, Consultant Haematologist,…

Read article
By UK SACT Board on 9th November 2026

New UK SACT Board National Intrathecal and Intraventricular SACT Guidance

Dear colleagues, We are pleased to share the newly published UK SACT Board National Guidance on the Safe Administration of Systemic Anti-Cancer Therapies via the Intrathecal or Intraventricular Routes. This…

Read article
By BOPA Executive Committee on 9th November 2026

BOPA members flying the flag for cancer pharmacy at ESMO 2026

It was fantastic to see BOPA members representing cancer pharmacy at ESMO Congress 2026 in Madrid, which brought together the global cancer community from 23 to 27 October to share…

Read article
By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article